Mutations in BRCA1 do not appear to contribute significantly to the risk of prostate cancer progression, according to DNA ...

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

HYDERABAD: Reiterating the state government’s goal to make Hyderabad the world’s “China Plus One” destination, Chief Minister ...

We recently published a list of 11 Best Performing Dow Stocks So Far in 2025. In this article, we are going to take a look at ...

Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre ...

The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further ...

Global biotech leader Amgen opened its $200 million technology and innovation centre in Hyderabad, a facility that will help ...

US-based biopharma giant on Monday opened its new technology and innovation centre in Hyderabad with its CEO Robert Bradway ...

Amgen, a leading American biopharmaceutical company, is set to invest $200 million in a new Technology and Innovation Centre.

Amgen invests $200M in India's tech center to leverage AI for drug development. The U.S. FDA seeks to rehire 300 staff ...

Amgen (AMGN) plans to invest about $200M this year in its new technology center in southern India, with further investments planned, Reuters’ ...